Familial partial lipodystrophy is an autosomal dominant disease caused by mutations of the LMNA gene encoding alternatively spliced
lamins A and C. Abnormal distribution of body fat and
insulin resistance characterize the clinical phenotype. In this study, we analyzed primary fibroblast cultures from a patient carrying an R482L
lamin A/C mutation by a morphological and biochemical approach. Abnormalities were observed consisting of nuclear
lamin A/C aggregates mostly localized close to the nuclear lamina. These aggregates were not bound to either
DNA-containing structures or RNA splicing intranuclear compartments. In addition,
emerin did not colocalize with nuclear
lamin A/C aggregates. Interestingly,
emerin failed to interact with
lamin A in R482L mutated fibroblasts in vivo, while the interaction with
lamin C was preserved in vitro, as determined by coimmunoprecipitation experiments. The presence of
lamin A/C nuclear aggregates was restricted to actively transcribing cells, and it was increased in
insulin-treated fibroblasts. In fibroblasts carrying
lamin A/C nuclear aggregates, a reduced incorporation of
bromouridine was observed, demonstrating that mutated
lamin A/C in FPLD cells interferes with
RNA transcription.